Description: This poster session highlights emerging therapeutic strategies in hypertrophic cardiomyopathy, from myosin inhibitors and metabolic modulators to septal reduction techniques and gene-targeted approaches. Presenters will share clinical and translational data that illuminate the evolving landscape of HCM management, with a focus on symptom relief, disease modification, and improved patient outcomes. This is not a CE accredited session.

Moderator:
Robby Wu (University of South Florida)